APA
Hoppenbrouwers K., Kanra G., Roelants M., Ceyhan M., Vandermeulen C., Yurdakök K., Silier T., Dupuy M., Pehlivan T., Ozmert E. & Desmyter J. (19990527). Priming effect, immunogenicity and safety of an Haemophilus influenzae type b-tetanus toxoid conjugate (PRP-T) and diphtheria-tetanus-acellular pertussis (DTaP) combination vaccine administered to infants in Belgium and Turkey. : Vaccine.
Chicago
Hoppenbrouwers K, Kanra G, Roelants M, Ceyhan M, Vandermeulen C, Yurdakök K, Silier T, Dupuy M, Pehlivan T, Ozmert E and Desmyter J. 19990527. Priming effect, immunogenicity and safety of an Haemophilus influenzae type b-tetanus toxoid conjugate (PRP-T) and diphtheria-tetanus-acellular pertussis (DTaP) combination vaccine administered to infants in Belgium and Turkey. : Vaccine.
Harvard
Hoppenbrouwers K., Kanra G., Roelants M., Ceyhan M., Vandermeulen C., Yurdakök K., Silier T., Dupuy M., Pehlivan T., Ozmert E. and Desmyter J. (19990527). Priming effect, immunogenicity and safety of an Haemophilus influenzae type b-tetanus toxoid conjugate (PRP-T) and diphtheria-tetanus-acellular pertussis (DTaP) combination vaccine administered to infants in Belgium and Turkey. : Vaccine.
MLA
Hoppenbrouwers K, Kanra G, Roelants M, Ceyhan M, Vandermeulen C, Yurdakök K, Silier T, Dupuy M, Pehlivan T, Ozmert E and Desmyter J. Priming effect, immunogenicity and safety of an Haemophilus influenzae type b-tetanus toxoid conjugate (PRP-T) and diphtheria-tetanus-acellular pertussis (DTaP) combination vaccine administered to infants in Belgium and Turkey. : Vaccine. 19990527.